Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDB1 | Q16531 | 1/20 | 0.37 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 2/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6211599 | 0.80 | MAOB (0.46) | DDB1CRBNHTTMAOB | |
| SCHEMBL3051430 | 0.76 | ALDH1A1 (0.44) | DDB1CRBNHTTGAAPOLB | |
| SCHEMBL31300144 | 0.76 | DDB1 (0.41) | DDB1CRBNHTTGAAPOLB | |
| SCHEMBL28260107 | 0.76 | KMT2A (0.43) | DDB1CRBNHTTGAAPOLB | |
| SCHEMBL1963328 | 0.76 | CRBN (0.41) | DDB1CRBNHTTGAAPOLB | |
| SCHEMBL837901 | 0.76 | DDB1 (0.60) | DDB1CRBNPOLBKMT2AMAOB | |
| SCHEMBL7126821 | 0.73 | PSEN1 (0.45) | — | |
| SCHEMBL28261454 | 0.73 | DDB1 (0.39) | DDB1CRBNHTTGAAPOLB | |
| SCHEMBL28103924 | 0.73 | PSEN1 (0.43) | DDB1CRBNHTT | |
| SCHEMBL28206454 | 0.73 | HTT (0.48) | CRBNHTTGAAPOLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4737448-A1 | SARM1 ENZYME ACTIVITY INHIBITOR AND USE THEREOF | Artivila (ShenZhen) Innovation Center, Ltd. (CN) | 2026-05-06 | — | — | EP | disclosed |
| WO-2025002030-A1 | SARM1 ENZYME ACTIVITY INHIBITOR AND USE THEREOF | 科辉智药(深圳)新药研究中心有限公司 | 2025-01-02 | — | — | WO | disclosed |